[1]
“Microbial Exopolysaccharides by Bacillus Subtilis as Pharmaceuticals”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 15, no. 2, pp. 863–872, May 2026, doi: 10.61096/ijrpp.v15.i2.2026.863-872.